E-mail Article

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.

* From Email:

* To Email:

To Email:

Email Subject Line:

Comments:

Dexmedetomidine: a guide to its use for sedation in the intensive care unit in the EU

Keating GM et al. – Intravenous dexmedetomidine provides an effective and generally well tolerated option for short– or longer–term primary sedation for patients in the intensive care unit (ICU) setting. It reduces the need for rescue sedation and opioids, and patients sedated with dexmedetomidine are calm and easy to arouse and manage. Moreover, dexmedetomidine is similar to propofol and midazolam in maintaining target sedation levels in ventilated ICU patients requiring longer–term sedation. [more...]

Drugs & Therapy Perspectives

Stay current on the latest literature, research and clinical news
Get special communications and offers from MDLinx and our sponsors
Receive invitations to paid market research

View Samples and Register

Stay current - Media Tool

Newsletter

RSS

Facebook

Receive free subspecialty
"5-minute updates" via email

Send the E-mail Newsletter to a Colleague

♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦

♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦

♦ Follow Us on Facebook

Search the latest
Nurse Practitioner Jobs
@MDLinx Career Center
View the full listing of nursing jobs

Enter your email address and your password will be sent to you.
Email:

E-mail:
Password:
	Remember me Forgot your password?